Researchers identify blood-based biomarkers that could help personalize treatment for autoimmune diabetes
Researchers at Bar-Ilan University's Azrieli Faculty of Medicine have identified blood biomarkers that accurately predict which mice would respond to an experimental combination therapy for latent autoimmune diabetes in adults (LADA), a form of autoimmune diabetes that is frequently mistaken for type 2 diabetes. The findings, published in MedComm, also show that the treatment restored normal…
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
For veterans with mild traumatic brain injury, a restaurant or other noisy environment can feel like a battlefield
United Kingdom
-
Cannabis use linked to higher death rates in people with alcohol-associated hepatitis
United Kingdom
-
Novel pacemaker technique reduced cardiac events in people with a heart rhythm disorder
United Kingdom
-
Q&A: Researcher investigates pharmacological approaches to breast cancer prevention
United Kingdom
-
Dissolving blood clots with flow-generating microbots
United Kingdom
-
Blood pressure medication combo linked to fewer irregular heart rhythms after ablation
United Kingdom
-
Your Instagram can predict how lonely you are
United Kingdom
-
Liver transplant linked to significantly extended survival for alcohol-associated disease yet access is not equitable
United Kingdom